IMPAKT 2014: Information for Media Representatives
Xenografts and mathematical modelling; liquid biopsy; nanotechnology; next generation genomics… Science is running fast and the impact of new technologies in the care of patients with breast cancer will be at the core of the sixth edition of the IMPAKT conference on translational research in breast cancer.
How to best develop and better individualise new strategies to fight against breast cancer? Worldwide experts and researchers will try to answer this and other crucial questions, accelerating knowledge transfer from researchers to clinicians, for the ultimate benefit of cancer patients.
- Abstract 1P – Detection of breast cancer and abnormal mammograms with a rapid point-of-care breath test, M. Phillips
- Abstract 5P – The clinical impact of using the IHC4 Score: our MDT experience in a prospective series of postmenopausal women with ER positive early breast cancer, B.J. Yeo
- Abstract 11P – Optimal duration of cardiac monitoring in metastatic HER2 positive breast cancer patients receiving trastuzumab, K. Chiu
- Abstract 14P – Adoption of multi-gene assays in HR+, HER2– breast cancer (BC) patients in Europe: results of the Multidisciplinary Application of Genomics in Clinical Practice (MAGIC) survey, M.S. Aapro
- Abstract 17P – The BRCA cancer gene as a useful predictor for double primary breast and ovarian cancer: A meta-analysis, A. Sattaratnamai
- Abstract 69P – Safety and efficacy of MK-8669 (Ridaforolimus) + MK-2206 (AKT inhibitor) in patients with advanced breast cancer with PI3K pathway dependence, S. Gupta
- Abstract 70P – Phase I/IIa study with CNS-targeted liposomal doxorubicin (2B3-101) in patients with brain metastases (BM) from breast cancer (BC) and other brain tumours, P.G. Aftimos
The conference will offer interesting discussions and presentations on the following topics:
- Patient-derived tumour xenografts as models for breast cancer drug development: problems, pitfalls and future directions
- Liquid biopsies: a convenient tool to monitor response and resistance to targeted therapies
- Molecular sequencing: ethical, legal and social implications
- Clinical implications of immune modulation in breast cancer
- Dissecting cancer through mathematics: from the cell to the animal model
BIG and ESMO welcome media interested in obtaining information and reporting on cancer issues. Registration is free to bona fide journalists on presentation of a letter of assignment and a valid press card.
Media representatives are required to observe and abide by the IMPAKT Media Policy.
To register for the event, please complete Media Registration Form. Media registration in advance is strongly recommended although on-site registration will still be possible.
Further information for press representatives will be made available regularly. Please contact the IMPAKT Press Office if you already want to schedule interviews or for any additional question.
On-site Press Room opening hours
Registered journalists can access all conference sessions and the IMPAKT Press Room.
|Thursday 8 May 2014||10:00 – 18:00|
|Friday 9 May 2014||08:00 – 18:00|
|Saturday 10 May 2014||08:00 – 13:00|
IMPAKT Press Office
c/o ESMO Press Office
Follow all the news and updates from the conference on Twitter by using the hashtag #IMPAKT14